OP-ED: J&J ‘Pause’ Underscores What Government Gets Wrong About Risk
Inside Sources – ICLE Director of Law & Economics Programs Gus Hurwitz had an op-ed in Inside Sources looking at the decision by the FDA and CDC to pause the Johnson & Johnson COVID-19 vaccine, and what it tells us about federal agencies’ approach to risk. You can read the full piece here.
Just 10 days after issuing it, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention lifted their “pause” on the use of the Johnson & Johnson COVID-19 vaccine. Initially sparked by six reported cases of a rare blood clot, out of more than 6.8 million doses administered, the decision also came amid a pandemic that continues to infect 50,000 more Americans every day.